Vaxxinity Inc expected to post a loss of 16 cents a share - Earnings Preview

Vaxxinity

05/05/2023 11:41

* Vaxxinity Inc  VAXX.OQ   VAXX.O  is expected to show no
change
in quarterly revenue when it reports  results on May 8
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Vaxxinity Inc is
for a
loss of 16 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Vaxxinity
Inc is
$12.5​, above​ its last closing price of $2.20. ​​​

This summary was machine generated May 5 at 10:41 GMT.  All
figures in US dollars  unless otherwise stated